NASDAQ:EVOK

Evoke Pharma - EVOK News Today

$1.89

-0.12 (-5.97%)

(As of 03/30/2023 12:00 AM ET)

Add

Compare

Today's Range: $1.80
▼
$1.98
50-Day Range: $1.89
▼
$5.75
52-Week Range: $1.37
▼
$16.80

Volume: 24,507 shs
Average Volume: 17,533 shs
Market Capitalization: $6.31 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Institutional Ownership

Get Evoke Pharma News Delivered to You Automatically

EVOK Media Mentions By Week

EVOK Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

EVOK
News Sentiment
▼
0.72

0.60
▲
Average
Medical
News Sentiment

EVOK News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

EVOK Articles
This Week
▼
5

1
▲
EVOK Articles
Average Week

Source

Source	Headline
	Evoke Pharma, Inc. (NASDAQ:EVOK) Short Interest Up 42.5% in March americanbankingnews.com - March 31 at 6:24 AM
	StockNews.com Initiates Coverage on Evoke Pharma (NASDAQ:EVOK) americanbankingnews.com - March 25 at 1:50 AM
	Evoke Pharma, Inc. (NASDAQ:EVOK) Q4 2022 Earnings Call Transcript finance.yahoo.com - March 24 at 8:39 AM
	Evoke Pharma (NASDAQ:EVOK) Releases Earnings Results americanbankingnews.com - March 24 at 7:20 AM
	Evoke Pharma & EVERSANA Announce Compelling Real-World Data on the Impact of GIMOTI in Reducing the Utilization of Healthcare Resources to be Presented at the Academy of Managed Care Pharmacy (AMCP) 2023 finance.yahoo.com - March 23 at 9:42 AM
	Evoke Pharma, Inc.: Evoke Pharma Reports Fourth Quarter and Full Year 2022 Financial Results finanznachrichten.de - March 22 at 7:54 AM
	Glow Launches New Brand Identity to Underscore Its High-Performance, Technology-Driven Portfolio of Natural Ingredients benzinga.com - March 22 at 7:54 AM
	Evoke Pharma Shares Up 4.8% on Higher 4Q Sales marketwatch.com - March 21 at 8:29 PM
	Evoke Pharma Reports Fourth Quarter and Full Year 2022 Financial Results finance.yahoo.com - March 21 at 8:29 PM
	Gastroenterology Market: The Growing Trend 2030 marketwatch.com - March 21 at 5:27 AM
	2023 Diabetic Gastroparesis Market Size, Trends, Growth, Share, Business Analysis, Key Players, Merger, Statistics, Competitive Landscape marketwatch.com - March 20 at 5:34 PM
	Evoke Pharma is about to announce its earnings — here's what to expect markets.businessinsider.com - March 20 at 12:34 PM
	Evoke Pharma to Report Fourth Quarter and Full Year 2022 Results on March 21, 2023 finance.yahoo.com - March 15 at 2:31 PM
	Diabetic Gastroparesis Market Future Trends Demand 2023, and Forecast to 2028 marketwatch.com - February 23 at 5:34 PM
	Gastroenterology Market International Business Analysis, Development Outlook and Regional Strategies 2028 marketwatch.com - February 22 at 3:53 AM
	Evoke Pharma and EVERSANA Selected to Present Results of Real-World Healthcare Utilization Study Comparing GIMOTI® and Oral Metoclopramide at the Digestive Disease Week Plenary Session finance.yahoo.com - February 21 at 7:33 AM
	Gastroenterology Market 2023 : Incredible Possibilities, Growth Analysis and Forecast To 2028 marketwatch.com - February 18 at 8:14 AM
	Evoke stock rises on filing of dismissal in nasal spray Gimoti's patent infringement case msn.com - January 30 at 3:55 PM
	Evoke Announces Teva Ends Pursuit of Paragraph IV ANDA Against Gimoti finance.yahoo.com - January 30 at 10:55 AM
	Evoke Pharma Announces Acceptance of an Abstract at the Academy of Managed Care Pharmacy (AMCP) Annual Meeting 2023 finance.yahoo.com - January 18 at 10:12 AM
	Evoke Pharma forbes.com - January 5 at 12:48 AM
	Evoke Pharma's Return On Capital Employed Insights msn.com - December 14 at 1:09 PM
	USPTO Grants New Patent to Evoke Pharma Covering the Usage of GIMOTI® To Treat Moderate to Severe Gastroparesis finance.yahoo.com - December 7 at 9:27 AM
	Evoke Pharma Strengthens its Intellectual Property Portfolio with a Notice of Allowance from the USPTO for a Patent Application Related to GIMOTI® finance.yahoo.com - November 30 at 1:21 PM
	Evoke Pharma Third Quarter 2022 Earnings: Beats Expectations finance.yahoo.com - November 12 at 9:55 AM
	Evoke Pharma, Inc. (EVOK) Q3 2022 Results - Earnings Call Transcript seekingalpha.com - November 10 at 12:25 AM
	Evoke Pharma Reports Record Third Quarter 2022 Financial Results finance.yahoo.com - November 9 at 7:24 PM
	Earnings Preview: Evoke Pharma msn.com - November 8 at 6:48 PM
	Evoke Pharma earnings: here's what Wall Street expects markets.businessinsider.com - November 8 at 1:44 PM
	Evoke Pharma to Report Third Quarter Results on November 9, 2022 finance.yahoo.com - November 2 at 7:32 PM
	Evoke Pharma (NASDAQ: EVOK) fool.com - October 21 at 7:50 PM
	Evoke Pharma to Participate in the 2022 American College of Gastroenterology Annual Scientific Meeting finance.yahoo.com - October 20 at 9:52 AM
	EVOK Evoke Pharma, Inc. seekingalpha.com - September 20 at 10:05 PM
	Evoke Pharma Receives Notice of Allowance from USPTO for a Patent Related to GIMOTI finance.yahoo.com - September 20 at 5:02 PM
	GIMOTI Receives Nomination for 2022 Healio Industry Breakthrough Award finance.yahoo.com - September 14 at 1:18 PM
	Evoke Pharma to Participate in H.C. Wainwright 24th Annual Global Investment Conference finance.yahoo.com - September 6 at 9:51 AM
	Gastroparesis Treatment Market Analysis/Research Report 2022 - Strong Promising Pipelines Developed by Key Players - ResearchAndMarkets.com apnews.com - August 29 at 7:05 AM
	Evoke Pharma and EVERSANA Expand Patient Access to GIMOTI® With New Telehealth Solution finance.yahoo.com - August 16 at 12:08 PM
	Colistin Sulphate Market- Who are the Key Players in Industry and How are They Performing in recent years? – Analysis and Forecasts to 2029 marketwatch.com - August 10 at 8:37 PM
	Evoke Pharma, Inc. (EVOK) CEO David Gonyer on Q2 2022 Results - Earnings Call Transcript seekingalpha.com - August 10 at 8:37 PM
	Evoke Pharma Reports Second Quarter 2022 Financial Results finance.yahoo.com - August 10 at 8:37 PM
	Evoke Pharma to Report Second Quarter Results on August 10, 2022 finance.yahoo.com - August 3 at 10:18 AM
	Evoke Pharma Recognizes Gastroparesis Awareness Month through its Support of The International Foundation for Gastrointestinal Disorders (IFFGD) finance.yahoo.com - August 1 at 12:00 PM
	Evoke Pharma Expands IP Portfolio with Addition of Canadian Patent Covering GIMOTI Method of Use finance.yahoo.com - July 6 at 10:20 AM
	Evoke jumps on approval for nasal spray Gimoti being added to Florida's Medicaid program seekingalpha.com - June 15 at 1:19 PM
	Evoke Pharma Shares Jump 72% After Gimoti Added to Florida Preferred Drug List marketwatch.com - June 15 at 1:19 PM
	Evoke Pharma Bounces Back From Tuesday's 52-Week Low marketwatch.com - June 15 at 1:19 PM
	Evoke Pharma Announces Approval of GIMOTI® to Florida State Medicaid Program finance.yahoo.com - June 15 at 1:19 PM
	Evoke Pharma (EVOK) Stock Soars 50% on Medicaid Drug Approval investorplace.com - June 15 at 11:01 AM
	Evoke Pharma Regains Compliance with Nasdaq Listing Requirements and Provides Financial Update finance.yahoo.com - June 8 at 11:39 AM

Get Evoke Pharma News Delivered to You Automatically

This page (NASDAQ:EVOK) was last updated on 3/31/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Evoke Pharma - EVOK News Today

EVOK Media Mentions By Week

EVOK Media Sentiment

EVOK News Coverage

About MarketBeat

Popular Tools

Financial Calendars

Terms & Info